Todd C Brady is President and CEO of Aldeyra Therapeutics, Inc.. Currently has a direct ownership of 1.47 Million shares of ALDX, which is worth approximately $7.78 Million. The most recent transaction as insider was on Mar 12, 2024, when has been sold 85,324 shares (Common Stock) at a price of $3.05 per share, resulting in proceeds of $260,238. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.47M
0% 3M change
11.07% 12M change
Total Value Held $7.78 Million

Todd C Brady Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 12 2024
SELL
Open market or private sale
$260,238 $3.05 p/Share
85,324 Reduced 5.48%
1,471,298 Common Stock
Mar 11 2024
SELL
Open market or private sale
$320,178 $3.27 p/Share
97,914 Reduced 5.92%
1,556,622 Common Stock
Sep 07 2023
SELL
Payment of exercise price or tax liability
$532,886 $7.22 p/Share
73,807 Reduced 4.27%
1,654,536 Common Stock
Sep 07 2023
BUY
Exercise of conversion of derivative security
$150,181 $0.55 p/Share
273,058 Added 13.64%
1,728,343 Common Stock
Feb 28 2023
BUY
Grant, award, or other acquisition
-
238,750 Added 14.09%
1,455,285 Common Stock
Jun 23 2022
BUY
Open market or private purchase
$59,472 $3.36 p/Share
17,700 Added 1.43%
1,216,535 Common Stock
Mar 30 2022
BUY
Grant, award, or other acquisition
-
250,000 Added 17.26%
1,198,835 Common Stock
Apr 12 2021
BUY
Grant, award, or other acquisition
-
46,619 Added 4.68%
948,835 Common Stock

Also insider at

FSTX
F-star Therapeutics, Inc. Healthcare
EVOK
Evoke Pharma Inc Healthcare
TCB

Todd C Brady

President and CEO
Lexington, MA

Track Institutional and Insider Activities on ALDX

Follow Aldeyra Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALDX shares.

Notify only if

Insider Trading

Get notified when an Aldeyra Therapeutics, Inc. insider buys or sells ALDX shares.

Notify only if

News

Receive news related to Aldeyra Therapeutics, Inc.

Track Activities on ALDX